Clinical and socioeconomic factors associated with recurrent atrial fibrillation after catheter ablation or antiarrhythmic drug therapy by Jaejin An, PhD, Nisha Bansal, MD, Chengyi Zheng, PhD, Ming-Sum Lee, MD, PhD, Rong Wei, MA, Teresa N. Harrison, SM, Dongjie Fan, MS, Elisha Garcia, MS, Benjamin Lidgard, MD, Leila R. Zelnick, PhD, Daniel E. Singer, MD, Alan S. Go, MD

Get full text

Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT‐AF by Jeffrey B. Washam, DaJuanicia N. Holmes, Laine E. Thomas, Sean D. Pokorney, Elaine M. Hylek, Gregg C. Fonarow, Kenneth W. Mahaffey, Bernard J. Gersh, Peter R. Kowey, Jack E. Ansell, Alan S. Go, James A. Reiffel, James V. Freeman, Daniel E. Singer, Gerald Naccarelli, Rosalia Blanco, Eric D. Peterson, Jonathan P. Piccini

Get full text